» Articles » PMID: 23242649

Evaluation of Ovarian and Testicular Tissue Cryopreservation in Children Undergoing Gonadotoxic Therapies

Overview
Publisher Springer
Date 2012 Dec 18
PMID 23242649
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Ovarian and testicular tissue cryopreservation are the only fertility preservation options for sexually immature individuals. Because of their experimental nature, it is important to determine safety and possible bundling with other medicallyindicated procedures.

Study Design: Prospective observational.

Results: Cryopreservation indications included cancer in 75 % of females and 50 % of males, while non-cancer indications included various hematological conditions. Similar numbers of females (12/28) and males (3/9) underwent prior chemotherapy. Females underwent laparoscopic (27/28) or robotic (1/28) approaches while incisional biopsy was used in males. Bundling of ovarian and testicular harvesting with other medicallyindicated procedures was performed in 42 % and 22 %, respectively. The operative time inclusive of bundled procedures was similar (1.6 ± 0.1 vs. 0.9 ± 0.3 h) but the discharge time was significantly longer for females than males (10.4 ± 0.6 vs. 4.6 ± 0.6 h, p<0.05) due to frequent bundling of medically-indicated procedures in females. All procedures were successfully completed without complications or significant blood loss.

Conclusions: Pediatric gonadal tissue cryopreservation can be combined with other medically-indicated procedures to minimize the potential inconvenience, additional anesthetic risks, and costs.

Citing Articles

Trends in fertility preservation treatments in Japan until 2023: analysis of the Japan Oncofertility Registry.

Kawai T, Harada M, Urata Y, Sanada Y, Kaneda Y, Takai Y Int J Clin Oncol. 2025; .

PMID: 40016481 DOI: 10.1007/s10147-025-02725-1.


Ovarian Tissue Cryopreservation versus Other Fertility Techniques for Chemoradiation-Induced Premature Ovarian Insufficiency in Women: A Systematic Review and Future Directions.

Chaudhri E, Salman A, Awartani K, Khan Z, Hashmi S Life (Basel). 2024; 14(3).

PMID: 38541717 PMC: 10972149. DOI: 10.3390/life14030393.


A 16-year bicentric retrospective analysis of ovarian tissue cryopreservation in pediatric units: indications, results, and outcome.

Grellet-Grun M, Delepine B, Van Quyen P, Averous G, Durlach A, Greze C Front Endocrinol (Lausanne). 2023; 14:1158405.

PMID: 37720539 PMC: 10501795. DOI: 10.3389/fendo.2023.1158405.


Spermatogonial Stem Cell-Based Therapies: Taking Preclinical Research to the Next Level.

Sanou I, van Maaren J, Eliveld J, Lei Q, Meissner A, de Melker A Front Endocrinol (Lausanne). 2022; 13:850219.

PMID: 35444616 PMC: 9013905. DOI: 10.3389/fendo.2022.850219.


Fertility preservation in boys: recent developments and new insights .

Goossens E, Jahnukainen K, Mitchell R, van Pelt A, Pennings G, Rives N Hum Reprod Open. 2020; 2020(3):hoaa016.

PMID: 32529047 PMC: 7275639. DOI: 10.1093/hropen/hoaa016.


References
1.
Quinn G, Murphy D, Knapp C, Stearsman D, Bradley-Klug K, Sawczyn K . Who decides? Decision making and fertility preservation in teens with cancer: a review of the literature. J Adolesc Health. 2011; 49(4):337-46. PMC: 3179606. DOI: 10.1016/j.jadohealth.2011.01.005. View

2.
Copelan E . Hematopoietic stem-cell transplantation. N Engl J Med. 2006; 354(17):1813-26. DOI: 10.1056/NEJMra052638. View

3.
Wallace W, Shalet S, Crowne E, Gattamaneni H . Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol (R Coll Radiol). 1989; 1(2):75-9. DOI: 10.1016/s0936-6555(89)80039-1. View

4.
Ginsberg J, Carlson C, Lin K, Hobbie W, Wigo E, Wu X . An experimental protocol for fertility preservation in prepubertal boys recently diagnosed with cancer: a report of acceptability and safety. Hum Reprod. 2009; 25(1):37-41. PMC: 2794668. DOI: 10.1093/humrep/dep371. View

5.
Soleimani R, Heytens E, Darzynkiewicz Z, Oktay K . Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise. Aging (Albany NY). 2011; 3(8):782-93. PMC: 3184979. DOI: 10.18632/aging.100363. View